Drug Trial Radar · NCT06496607
A Study to Evaluate Solriktug in Adult Participants With Asthma
Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
145
Actual
Start
Jul 26, 2024
Primary completion
Jul 6, 2026
Study completion Oct 26, 2026
Sponsor
- Lead sponsor
- Uniquity One (UNI)Industry
- Sponsor type
- Industry
- Collaborators
- DevPro Biopharma
- First posted
- Jul 11, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma.
Conditions
- Asthma
Interventions
NSI-8226Biological
Solrikitug
NSI-8226Biological
Solrikitug
NSI-8226Biological
Solrikitug
PlaceboBiological
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- To assess the effect of multiple doses of solrikitug on blood eosinophil counts compared with placeboTime frame: Over weeks 8 and 12
Locations
69 sites in 1 country. Site status is shown where the registry gives one.
Velocity Clinical Research
Mobile, Alabama
Phoenix Medical Group
Peoria, Arizona
Warren W. Pleskow, M.D.
Encinitas, California
Beach Physicians Clinical Research Corp.
Huntington Beach, California
Biosolutions Clinical Research Center
La Mesa, California
Orso Health
Long Beach, California
Downtown LA Research Center
Los Angeles, California
Newport Native MD, Inc.
Newport Beach, California
Prospective Research Innovations Inc.
Rancho Cucamonga, California
Allergy & Asthma Medical Group and Research Center
San Diego, California
Allergy & Asthma Associates of Santa Clara Valley
San Jose, California
San Jose Clinical Trials
San Jose, California
North Bay Clinical Research
Santa Rosa, California
Providere Research
West Covina, California
Velocity Clinical Research - Denver
Englewood, Colorado
JY Research Institute
Cutler Bay, Florida
Hillcrest Medical Research, LLC
DeLand, Florida
Clinical Site Partners LLC dba-Leesburg
Leesburg, Florida
Pharmax Research of South Florida
Miami, Florida
Coral Research Clinic Corp.
Miami, Florida
Pro-Care Research Center, Corp.
Miami Gardens, Florida
Ogden Clinical Canyon View
Tallahassee, Florida
Care Access, Tamarac
Tamarac, Florida
TBC Research
Tamarac, Florida
National Clinical Trials
Cordele, Georgia
CPCC - Research, LLC
East Point, Georgia
Aeroallergy Research Laboratories of Savannah, Inc.
Savannah, Georgia
NexGen Research
Boise, Idaho
Treasure Valley Medical Research
Boise, Idaho
Accellacare - Duly
Winfield, Illinois
Velocity Clinical Research - Sioux City
Sioux City, Iowa
Velocity Clinical Research
Lafayette, Louisiana
Chesapeake Clinical Research, Inc.
White Marsh, Maryland
Mayflower Clinical
South Dartmouth, Massachusetts
Deerborn Clinic
Dearborn, Michigan
Henry Ford Health System
Detroit, Michigan
Pulmonary Research Institute of SE Michigan
Farmington Hills, Michigan
Revive Research Institute, Inc.
Southfield, Michigan
Montana Medical Research, Inc.
Missoula, Montana
Henderson Trials
Henderson, Nevada
Showing 40 of 69 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.